Approval · Notice of Compliance 18694 · 2016
DOTAREM: Notice of Compliance 18694
Issued November 25, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18694
- Date
- November 25, 2016
- Company
- GuerbetRoissy Cdg Cedex, Val-D'Oise, France
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOTAREM | 02459329 | Marketed |
Medicinal ingredients
- GADOTERATE MEGLUMINE 376.9 MG per ML